2026 NPPES data Psychiatric Pharmacist NPI 1609259662
Verify on CMS →

GLEN CHASE

Psychiatric Pharmacist in YAKIMA, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
714
Medicare Part D claims · 33 beneficiaries · Psychiatric Pharmacist avg: 396
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: GLEN CHASE is a Psychiatric Pharmacist ([object Object]) practicing in YAKIMA, Washington with a Medicare Part D prescribing footprint of 714 claims across 33 beneficiaries — 9% brand-name prescribing .

What stands out: GLEN CHASE filed 714 Medicare Part D claims in 2023 across YAKIMA, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

GLEN CHASE at a glance

Quality data not reported

NPI registry status

Active

Issued 07/08/2015

NPI 1609259662

Primary specialty

Psychiatric Pharmacist

Niche

837 US NPIs in this specialty

Medicare Part D claims

714 80% vs specialty avg

2023 prescription claims

Specialty avg: 396

Specialty distribution in Washington

How Psychiatric Pharmacist compares to other specialties among Washington providers

Washington providers

Psychiatric Pharmacist share within Washington

1. Psychiatric Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Psychiatric Pharmacist share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Psychiatric Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Psychiatric Pharmacist ABMS/AOA estimate

Est. board-certified rate (Psychiatric Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Psychiatric Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GLEN CHASE is a Psychiatric Pharmacist provider practicing in YAKIMA, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1609259662. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

GLEN CHASE appears in the CMS NPPES registry as a Psychiatric Pharmacist provider at 402 S 4TH AVE, YAKIMA, WA, 98902, with a listed phone of (509) 575-4084. NPI 1609259662 was issued on 07/08/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHASE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 714 prescription claims written by this provider, covering 33 Medicare beneficiaries and totaling roughly $253K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Psychiatric Pharmacist is a narrow specialty nationwide, with 837 enrolled providers across 49 states and an average of 396 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

402 S 4TH AVE
YAKIMA, WA 98902

Provider Details

NPI 1609259662
Specialty Psychiatric Pharmacist
Gender Male
NPI Issued 07/08/2015

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to GLEN CHASE. To verify GLEN CHASE's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

GLEN CHASE — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 714 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

714
Total Claims
$253K
Total Drug Cost
33
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
734
Total Day Supply
19,212
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$217K
Generic Drug Cost
$36K

Patient Demographics

Average Patient Age
45.9 years
Avg HCC Risk Score
1.33
Gender Split
42% female / 58% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Quetiapine Fumarate
58
Benztropine Mesylate
42
Divalproex Sodium Er
Divalproex Sodium
39
Risperidone
38
Aripiprazole
37
Olanzapine
31
Fluphenazine Hcl
27
Lithium Carbonate Er
Lithium Carbonate
26
Invega Sustenna
Paliperidone Palmitate
25
Lamotrigine
25

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Psychiatric Pharmacist Overview

How GLEN CHASE fits within the Psychiatric Pharmacist landscape nationally.

837
Psychiatric Pharmacist Providers in US
49
States with Psychiatric Pharmacist
396
Avg Claims per Provider

GLEN CHASE's 714 claims are above the specialty average of 396.

Nearby Psychiatric Pharmacist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as CHASE.

Compare Psychiatric Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is GLEN CHASE's specialty?
GLEN CHASE specializes in Psychiatric Pharmacist and practices in YAKIMA, Washington.
How much does GLEN CHASE prescribe under Medicare Part D?
In 2023, GLEN CHASE wrote 714 Medicare Part D claims totaling $253K in drug costs for 33 beneficiaries.
Where is GLEN CHASE located?
GLEN CHASE is located at 402 S 4TH AVE, YAKIMA, WA, 98902. Phone: (509) 575-4084.
What is GLEN CHASE's NPI number?
GLEN CHASE's National Provider Identifier (NPI) is 1609259662, issued on 07/08/2015.
Does GLEN CHASE prescribe more brand-name or generic drugs?
GLEN CHASE's prescribing is 9% brand-name and 91% generic drugs by claim count, with $217K in brand drug costs.
How many Psychiatric Pharmacist providers are there in the US?
There are 837 Psychiatric Pharmacist providers across 49 states in the US. The average Psychiatric Pharmacist provider writes 396 Medicare Part D claims per year.
What drugs does GLEN CHASE prescribe most often?
Based on 2023 Medicare Part D data, GLEN CHASE's most frequently prescribed drugs include Quetiapine Fumarate, Benztropine Mesylate, Divalproex Sodium Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GLEN CHASE accept Medicare?
GLEN CHASE appears in CMS Medicare data with 714 Part D claims and 33 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GLEN CHASE's credentials?
GLEN CHASE's NPI is 1609259662. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology